NCCM
SCMP

Nine Chapters Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Nine Chapters Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$127K Buy
+10,800
New +$121K 0.28% 117
2017
Q2 		– Sell
-40,500
Closed -$446K – 252
2017
Q1 		$446K Buy
40,500
+28,700
+243% +$333K 0.6% 52
2016
Q4 		$160K Buy
11,800
+300
+3% +$4.18K 0.27% 132
2016
Q3 		$142K Buy
+11,500
New +$136K 1% 45

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nine Chapters Capital Management's SCMP Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017: 10,800 shares worth $127K. The stake represents 0.28% of the portfolio and ranks #117 among its holdings. This is a return to the name: Nine Chapters Capital Management previously reported a position in SCMP as recently as Q1 2017.

Nine Chapters Capital Management first reported a position in SCMP in Q3 2016 and has held it in 4 quarters since. The position peaked at $446K in Q1 2017. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Nine Chapters Capital Management held 10,800 shares of Sucampo Pharmaceuticals, Inc. worth $127K as of Q3 2017.
  • Sucampo Pharmaceuticals, Inc. was a new Nine Chapters Capital Management position in Q3 2017.
  • Sucampo Pharmaceuticals, Inc. made up 0.28% of Nine Chapters Capital Management's portfolio in Q3 2017, its #117 holding.
  • Nine Chapters Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2016 and has held it in 4 quarters since.
  • Nine Chapters Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $446K in Q1 2017.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.